Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - Time to Sell?

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $1.22, but opened at $1.13. Curaleaf shares last traded at $1.17, with a volume of 111,409 shares trading hands.

Curaleaf Price Performance

The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08. The business has a 50-day moving average price of $0.87 and a 200 day moving average price of $1.07. The stock has a market cap of $770.72 million, a PE ratio of -3.71 and a beta of 0.62.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. As a group, research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Recommended Stories

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines